Registered entity data
In general | |||
| Enterprise number: | 0445.922.856 | ||
| Status: | Active | ||
| Legal situation: | Normal situation Since December 9, 1991 | ||
| Start date: | December 9, 1991 | ||
| Name: | NEOGEN Name in Dutch, since October 27, 2006 | ||
| Registered seat's address: |
Square Marie Curie 50
1070 Anderlecht Since February 2, 2011 | ||
| Phone number: | No data included in CBE. | ||
| Fax: | No data included in CBE. | ||
| Email address: | No data included in CBE. | ||
| Web Address: | No data included in CBE. | ||
| Entity type: | Legal person | ||
| Legal form: |
Public limited company
Since December 9, 1991 | ||
| Number of establishment units (EU): | 1
Information and activities for each establishment unit | ||
| | |||
Functions | |||
| Director | 0780.621.851 | Since January 1, 2022 | |
| Director | 1011.807.988 | Since July 1, 2024 | |
| Permanent representative | Cardoso Simoes Febra , Bruno (0780.621.851) | Since January 1, 2022 | |
| Permanent representative | Matyasek , Libor (1011.807.988) | Since July 1, 2024 | |
| Managing Director | 1011.807.988 | Since July 1, 2024 | |
| | |||
Entrepreneurial skill - Travelling- Fairground operator | |||
| No data included in CBE. | |||
| | |||
Characteristics | |||
| Subject to VAT Since July 1, 2001 | |||
| Enterprise subject to registration Since November 1, 2018 | |||
| | |||
Authorisations | |||
| No data included in CBE. | |||
| | |||
Version of the Nacebel codes for the VAT activities 2008(1) | |||
| VAT 2008
21.201 -
Manufacture of medicaments Since January 1, 2008 | |||
| Show the activities for NACEBEL codification version 2003. | |||
| | |||
Financial information | |||
| Capital | 7.335.797,80 EUR | ||
| Annual assembly | June | ||
| End date financial year | 31 December | ||
| Start date exceptional fiscal year | January 1, 2006 | ||
| End date exceptional fiscal year | March 31, 2007 | ||
| | |||
Links between entities | |||
| 0808.426.110 (NEOGEN DEVELOPMENTS)
has been absorbed by this entity
since June 30, 2020 | |||
| 0820.918.621 (Nordic Specialty Pharma)
has been absorbed by this entity
since June 30, 2020 | |||
| 0843.767.069 (NEOGEN INTERNATIONAL)
has been absorbed by this entity
since June 30, 2020 | |||
| 0898.168.530 (Stasisport Pharma)
has been absorbed by this entity
since June 30, 2020 | |||
| | |||
External links | |||
|
Publications in National Gazette
Publication of the annual accounts in the Central Balance Sheet Office Database of statutes and powers of representation (notarial deeds) | |||
(1)Activities are registered in the CBE using NACE-BEL codes (Belgian classification of activities). There are different versions of these codes. Activities with a NACE-BEL code (version 2003) were stopped on 31/12/2007 and automatically converted to the new NACE-BEL codes (2008 version) starting on 01/01/2008. A new 2025 version of the codes will enter into force on 01/01/2025. During the first half of the year 2025, all activities with a 2008 version of the NACE-BEL code will be phased out with 31/12/2024 as end date and automatically converted to the 2025 version of the NACE-BEL codes, starting on 01/01/2025. Up until then, activities will continue to be registered using the 2008 NACE-BEL codes.
To top Back
